Hero Image Block
Hero Image Block
Hero Image Block
Hero Image Block

BIOTECH BRANDING SERVICES

EVIDENCE DEMANDS
CERTAINTY. STRATEGY
STARTS WITHOUT IT.

Branding isn’t
built on proof.
Biotech is.

Your science demands rigour. Every claim validated. Every mechanism evidenced. Every trial documented, peer-reviewed, defended. The temptation? Apply the same certainty to your brand. Define the positioning early. Lock down the narrative. Sound confident before you’ve earned it. Most biotech branding does exactly that. We take the opposite view.

Our biotech branding services begin with the questions your stakeholders are already asking. Can they explain what you do in a single sentence? Do investors, partners, and scientists hear the same story? When the platform pivots or the pipeline shifts, does the brand still hold? Difficult questions. The answers rarely arrive cleanly, and we won’t pretend they do. We sit with the ambiguity longer than feels comfortable, because that’s where the positioning everyone else missed is hiding. Certainty sells faster. It also ages badly.

You’ve seen
the playbook
before.

Commission the research. Confirm the assumptions. Pick a Latin-sounding name. Default to blue and white. Add a helix or two. Gesture at innovation. Launch. Move on. In a sector that runs on evidence, the process looks responsible. Every stage signed off. Every claim defensible. It’s efficient. It’s also why most biotech brands are invisible.

We’ve worked with enough life sciences organisations to know that script produces forgettable work. Platform biotechs that blur into every other platform biotech. Diagnostics companies indistinguishable from the competition. Therapeutic developers chasing the same visual tropes with the same innovation language. Biotech branding that cuts through starts somewhere less comfortable. Not knowing. Letting the investor narrative fight the scientific detail. Watching the positioning fall apart, then rebuilding it around something true. It takes longer. The work that lasts usually does.

minervax
Visual identity brings clarity
to a biotech breakthrough.

Biotech branding services. Six disciplines. One system.

Six disciplines. One integrated system. Applied to organisations where the science is complex and the stakeholders are sceptical.
Biotech brand strategy

Clarity from complexity. Eventually.

The same story won’t work for everyone. Multiple audiences with different depths of knowledge. Investors, partners, and scientists hear differently. And they’re all in the room. We develop strategy by finding the through-line that survives every audience. A positioning that holds. And clarifying what you might be sacrificing to get there.

Biotech brand positioning

Reframe the category. Not just your place in it.

Most biotechs position against competitors. We position to change how investors, partners, and collaborators see what’s possible. The kind of positioning that shapes conversations at conferences, survives due diligence, and scales with your pipeline.

Biotech naming services

The best names get rejected first.

Biotech naming carries weight others don’t. Scientific credibility, trademark complexity, cross-border clearance, URL scarcity. And naming by committee rarely survives contact with anything interesting. We push until the room is uncomfortable. That’s usually where the right name is hiding.

Visual identity for biotech brands

Going beyond the helix.

Investor decks. Scientific publications. Conference stands. Talent campaigns. Your visual identity has to work across all of them – without defaulting to the same molecule illustrations everyone else is using. Another molecule. Another helix. We design by removing what’s expected until what’s left is unmistakably yours.

Verbal identity for biotech companies

Scientific precision. Human connection. Both.

Biotech messaging walks a tightrope. Too technical and you lose investors. Too simple and you lose credibility with KOLs. Most companies fall off in one direction and stay there. We develop tone of voice frameworks that translate complex science without diluting it. From pipeline narratives to partnership announcements to the slides your CEO presents at JPM.

Brand guidelines for biotech organisations

Built to survive the real world.

Partner co-branding. Regulatory submissions. The scientist who joined after the rebrand. Your guidelines need to hold up when you’re not in the room to explain them. We build systems with enough structure for investor scrutiny and enough flexibility for the messy reality of a scaling biotech.

LUMEON
A new name and visual identity
illuminate patient care.

Where clarity
and credibility
aren’t optional.

This sector runs on belief as much as data. Platform biotechs translating complex science into investable narratives. Clinical-stage companies preparing for partnerships and trials communications. Diagnostics teams differentiating beyond technical specifications, where the spec sheet looks identical to three competitors. The story has to carry what the data alone can’t.

Spinouts building credibility without pretending maturity. Scaling teams aligning internal belief while recruiting competitive talent. Companies repositioning after a platform or indication pivot, where the old story no longer fits and the new one isn’t written. The common thread? Organisations where credibility and clarity aren’t finishing touches, applied once the science works. They’re load-bearing. Get the brand wrong here and the cost isn’t a softer quarter. It’s the partner who passes, the round that stalls, the hire who chooses someone else.

Specialists
in biotech
branding?

The ways a biotech brand breaks are well documented. New ones still surface. An advisory board that can’t agree who matters most. A platform story that outpaces the pipeline. Investors, partners and talent each needing a different depth of detail. Science and commercial, quietly describing two different companies.

We’d rather not call ourselves experts. Experts arrive with answers. The work here needs better questions, and the patience to sit with discomfort before resolving it. What we do have is range. Fabrik is a London-based branding agency with real life-sciences depth. From early-platform spinouts finding their first story to clinical-stage teams readying partnership and trials communications, diagnostics businesses to scaling therapeutics. Different science. Different stakes. Same way of working. Biotech branding specialists who start by questioning.

HRA HANA
Product naming for a global
self-care healthcare leader.
No marketing jargon, just insightful strategy, fresh creative thinking, and a collaborative approach. Fabrik crafted a distinctive new visual and verbal identity, including logo design, tone of voice, and brand guidelines. They struck the perfect balance between familiarity and innovation.
Per Fischer, M.Sc. D.Phil, CEO, MinervaX
View